Item 8.01 Other Events.
On January 21, 2021, Vuzix Corporation (the "Company"), filed a prospectus
supplement to its registration statement on Form S-3 Registration number
333-231932, pursuant to Rule 424(b)(5) under the Securities Act of 1933, as
amended, to register the sale of 674,084 shares of our common stock issuable
from time to time upon exercise of previously issued warrants. The warrants were
issued on December 14, 2017, have an exercise price of $7.00 per share, and will
be exercisable until June 18, 2021.
The opinion delivered to the Company by Sichenzia Ross Ference LLP in connection
with the sale of an aggregate of 674,084 shares of the Company's common stock
issuable upon exercise of outstanding warrants is being filed herewith in
accordance with the requirements of Item 601(b)(5) of Regulation S-K under the
Securities Act of 1933, as amended, and is incorporated by reference into the
Company's Registration Statement on Form S-3 (Registration No. 333-231932).
Item 9.01 Financial Statements and Exhibits.
Exhibit No Exhibit
5.1 Opinion of Sichenzia Ross Ference LLP
2
© Edgar Online, source Glimpses
VUZIX CORPORATION 
